Skip to main content
H.R. 8999 118th Congress House

Dialysis-Related Amyloidosis Treatment Act of 2024

Official title: To amend title XVIII of the Social Security Act to provide coverage and payment under such title for certain treatments for dialysis-related amyloidosis, and for other purposes.

Introduced: July 11, 2024 Introduced by: Brian Babin Republican · Texas See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Jul 11, 2024
Introduced in House
Jul 11, 2024
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 17, 2024

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Lobbying activity 2

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • KING & SPALDING LLP
    for KANEKA PHARMA AMERICA, LLC · California · 2nd Quarter 2025 (Apr 1 - June 30)
  • KING & SPALDING LLP
    for KANEKA PHARMA AMERICA, LLC · California · 1st Quarter 2025 (Jan 1 - Mar 31)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

 Cosponsors 2
All 2 Democratic 1 Republican 1
D
Nadler, Jerrold
New York · Jul 11, 2024
 R
Valadao, David G.
California · Jul 11, 2024
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 8999: Dialysis-Related Amyloidosis Treatment Act of 2024. 118th Congress. Open America. https://openamerica.io/bill/118-HR-8999/
MLA
"H.R. 8999: Dialysis-Related Amyloidosis Treatment Act of 2024." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-8999/.
Bluebook (legal)
H.R. 8999, 118th Cong. (2026), https://openamerica.io/bill/118-HR-8999/.
Markdown link
[H.R. 8999: Dialysis-Related Amyloidosis Treatment Act of 2024](https://openamerica.io/bill/118-HR-8999/)
Report a problem